自动uARC计划在食管癌同步推量放疗中的可行性研究

doi:10.3760/cma.j.cn113030-20220728-00260

摘要
图/表
参考文献
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的比较联影计划系统中食管癌同步推量自动uARC计划与人工计划的剂量学和放射生物学参数差异,为临床应用提供参考。方法选取100例同步推量食管癌患者的优质uARC计划,统计靶区和危及器官的剂量学参数均值,建立联影计划系统uRT-TPOIS智能计划的优化目标表。另选取21例食管癌病例作为测试病例,使用uRT-TPOIS计划系统分别设计人工计划和自动uARC计划。比较两种计划靶区的平均剂量D_mean、PTV的近似最小剂量D_98%和近似最大剂量D_2%、均匀性指数（HI）、适形指数（CI）、危及器官剂量、平均计划时间、机器跳数（MU）、肿瘤控制概率（TCP）和正常组织并发症概率（NTCP）的差异。符合正态分布的数据采用配对t检验比较两组数据的差异,不符合的采用非参数Wilcoxon检验。结果自动uARC计划的靶区D_98%（PTV_{60 Gy}：P<0.001,PTV_{54 Gy}：P=0.001）、CI（PTV_{60 Gy}：P<0.001,PTV_{54 Gy}：P=0.002）和处方剂量覆盖靶区体积（V_{54 Gy}：P<0.001）均优于人工计划,而D_mean和HI的差异无统计学意义[PTV_{54 Gy}（59.32±1.87）:（59.13±1.64）Gy,（0.19±0.02）:（0.18±0.02）,均为P>0.05];脊髓D_mean和D_max均优于人工计划[（13.22±4.27）:（13.75±4.44）Gy,P=0.020;（36.99±1.67）:（38.14±1.31）Gy,P=0.011];肺V_{20 Gy}两者差异无统计学意义（P>0.05）,但肺V_{5 Gy}和V_{10 Gy}均值人工计划均低于自动计划（均为P<0.001）。自动计划和人工计划的平均计划时间分别为（11.79±1.71） min和（53.36±8.23） min,两者差异有统计学意义（P<0.001）;和人工计划相比,自动计划没有增加跳数[（762.84±74.83）:（767.41±80.63） MU,P>0.05]。自动计划提高了靶区的TCP值（PTV_{60 Gy} 89.15%±0.49%:86.75%±6.46%,P=0.004和PTV_{54 Gy} 79.79%±3.48%:77.51%±5.04%,P=0.006）,增加了肺的NTCP值（0.46%±0.40%:0.35%±0.32%,P<0.001）。但心脏和脊髓的NTCP值,两种计划之间的差异无统计学意义（均为P>0.05）。结论使用联影智能计划模块实现食管癌自动uARC计划具有临床可行性,并且能够提高靶区适形性,缩短计划设计时间。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	梁恒坡
	陶金柱
	韩倩

关键词 ：食管肿瘤, 同步推量, 自动计划, 剂量学, 正常组织并发症

Abstract：Objective To compare dosimetric and radiobiological parameters between automatic and manual uARC plans in the treatment of esophageal cancer patients, aiming to provide reference for clinical application. Methods High-quality uARC plans of 100 patients with esophageal cancer were selected, and the mean values of the dosimetric parameters in the target area and organs at risk (OAR) were counted, and the goal table of uRT-TPOIS intelligent plan was established. Automatic and manual uARC plans were generated with UIH (United Imaging) treatment planning system (TPS) for 21 esophageal cancer patients. The differences in mean dose (D_mean), approximate minimum (D_98%) and maximum (D_2%) dose of planning target volume (PTV), homogeneity index (HI) and conformity index (CI), dose of OAR, mean planning time, monitor unit (MU), tumor control probability (TCP) and normal tissue complication probability (NTCP) were compared between automatic and manual uARC plans. Normally distributed data between two groups were compared by paired t-test, and non-normally distributed data were assessed by nonparametric Wilcoxon test. Results The D_98%(PTV_{60 Gy}: P<0.001, PTV_{54 Gy}: P=0.001) , CI (PTV_{60 Gy}: P<0.001, PTV_{54 Gy}: P=0.002) and target volume of area covered by prescription dose (V_{54 Gy}: P<0.001) of the automatic uARC plans were better than those of manual uARC plans (all P<0.05). There was no significant difference in D_mean or HI between the two plans [PTV_{54 Gy} (59.32±1.87) Gy vs. (59.13±1.64) Gy, (0.19±0.02) vs. (0.18±0.02), all P>0.05]. The D_mean and D_max of spinal cord of the automatic plan were better than those of the manual plan [(13.22±4.27) Gy vs. (13.75±4.44) Gy, P=0.020 and (36.99±1.67) Gy vs. (38.14±1.31) Gy, P=0.011]. There was no significant difference in the mean dose of V_{20 Gy} of the lung between two plans (P>0.05), whereas the mean doses of V_{5 Gy}and V_{10 Gy} of the lung of the manual plan were less than those of the automatic plan ( both P<0. 001). Automatic uARC plan had a significantly shorter mean planning time than manual uARC plan [(11.79±1.71) min vs. (53.36±8.23) min, P<0.001]. MU did not significantly differ between two plans [(762.84±74.83) MU vs. (767.41±80.63) MU, P>0.05]. The TCP of the automatic plan was higher than that of the manual plan (PTV_{60 Gy} 89.15%±0.49% vs. 86.75%±6.46%, P=0.004 and PTV_{54 Gy} 79.79%±3.48% vs. 77.51%±5.04%, P=0.006). However, manual plan had a lower NTCP of the lung than automatic uARC plan (0.46%±0.40% vs. 0.35%±0.32%, P<0.001). There was no significant difference in NTCP of heart and spinal cord between two plans (all P>0.05). Conclusion It is feasible to generate automatic uARC plan with uRT-TPOIS TPS for esophageal cancer patients, which can increase the target CI and shorten the plan design time.

Key words： Esophageal neoplasms Simultaneous integrated boost Auto-planning Dosimetry Normal tissue complication probability

收稿日期: 2022-07-28

通讯作者: 韩倩,Email：hq28022009@163.com

引用本文:

梁恒坡,陶金柱,韩倩. 自动uARC计划在食管癌同步推量放疗中的可行性研究[J]. 中华放射肿瘤学杂志, 2023, 32(7): 612-619.

Liang Hengpo,Tao Jinzhu,Han Qian. Feasibility study of automatic uARC planning for esophageal cancer using simultaneous integrated boost radiotherapy[J]. Chinese Journal of Radiation Oncology, 2023, 32(7): 612-619.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.cn113030-20220728-00260 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2023/V32/I7/612

[1] Netherton TJ, Cardenas CE, Rhee DJ, et al. The emergence of artificial intelligence within radiation oncology treatment planning[J]. Oncology, 2021,99(2):124-134. DOI: 10.1159/000512172.
[2] Tinoco M, Waga E, Tran K, et al. RapidPlan development of VMAT plans for cervical cancer patients in low- and middle-income countries[J]. Med Dosim, 2020,45(2):172-178. DOI: 10.1016/j.meddos.2019.10.002.
[3] Smith A, Granatowicz A, Stoltenberg C, et al.Can the student outperform the master? A plan comparison between pinnacle auto-planning and eclipse knowledge-based RapidPlan following a prostate-bed plan competition[J]. Technol Cancer Res Treat, 2019,18:1533033819851763. DOI: 10.1177/153303381985 1763.
[4] 张麒麟, 张书铭, 王明清, 等. 放疗自动计划研究进展[J].中华放射肿瘤学杂志,2021,30(3):316-320. DOI: 10.3760/cma.j.cn113030-20191202-00497.
Zhang QL, Zhang SM, Wang MQ, et al. Research progress on automatic treatment planning methods for radiotherapy[J].Chin J Radiat Oncol,2021,30(3):316-320. DOI: 10.3760/cma.j.cn113030-20191202-00497.
[5] 王翰林, 刘嘉城, 姚凯宁, 等. 基于优化参数树搜索算法的直肠癌调强放疗自动计划[J].中华放射医学与防护杂志,2021,41(1):66-73. DOI: 10.3760/cma.j.issn.0254-5098.2021.01.014.
Wang HL, Liu JC, Yao KN, et al. Automatic planning of IMRT for rectum cancer based on optimization parameters tree search algorithm[J].Chin J Radiol Med Prot,2021,41(1):66-73. DOI: 10.3760/cma.j.issn.0254-5098.2021.01.014.
[6] 吴骏翔, 康盛伟, 王培, 等. 宫颈癌术后放疗中自动计划与人工计划的剂量学比较[J]. 中华放射医学与防护杂志,2018,38 (1): 26-31. DOI: 10.3760/cma.j.issn.0254-5098.2018.01.006.
Wu JX, Kang SW, Wang P, et al. Dosimetric comparison between automated and manual volumetric modulated arc therapy planning for postoperative cervical cancer[J]. Chin J Radiol Med Prot, 2018,38(1):26-31. DOI:10.3760/cma.j.issn.0254-5098.2018.01.006.
[7] 张惠玲, 李鑫, 吴小良, 等. 分段弧和全弧旋转容积调强放疗治疗胸中段食管癌的剂量学比较[J].中国辐射卫生,2020,29(1):81-84. DOI: 10.13491/j.issn.1004-714X. 2020.01.019.
Zhang HL, Li X, Wu XL, et al. Dosimetry comparison of partial-arc and full-arc volumetric modulated arc therapy for middle esophageal cancer[J]. Chin J Radiol Health,2020,29(1):81-84. DOI: 10.13491/j.issn.1004-714X. 2020.01.019.
[8] 王清鑫, 江波, 孙佳娜, 等. 胸中下段食管癌弧内间断出束VMAT计划研究[J].中华放射肿瘤学杂志,2016,25(11):1238-1243. DOI: 10.3760/cma.j.issn.1004-4221.2016. 11.020.
Wang QX, Jiang B, Sun JN, et al. A study of finite discontinuity-volumetric modulated arc therapy for mid-and distal-esophageal carcinoma[J].Chin J Radiat Oncol,2016,25(11):1238-1243. DOI: 10.3760/cma.j.issn.1004-4221.2016.11.020.
[9] Chen H, Wang H, Gu HL, et al. Study for reducing lung dose of upper thoracic esophageal cancer radiotherapy by auto-planning: volumetric-modulated arc therapy vs intensity-modulated radiation therapy[J]. Med Dosim, 2018,43(3):243-250. DOI: 10.1016/j.meddos.2017. 09.001.
[10] 中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会. 中国食管癌放射治疗指南(2021年版)[J].国际肿瘤学杂志,2022,49(1):12-25. DOI: 10.3760/cma.j.cn371439-20211021-00002.
Chinese Medical Doctor Association Radiation Oncology Physicians Branch, Chinese Society of Radiation Oncology of Chinese Medical Association, Cancer Radiotherapy Professional Committee of China Anti-Cancer Association. Chinese guidelines for radiotherapy of esophageal cancer (2021 ed)[J]. J Int Oncol,2022,49(1):12-25. DOI:10.3760/cma.j.cn371439-20211021-00002.
[11] Feuvret L, Noël G, Mazeron JJ, et al. Conformity index: a review[J]. Int J Radiat Oncol Biol Phys, 2006,64(2):333-342. DOI: 10.1016/j.ijrobp.2005.09.028.
[12] International Commission on Radiation Units and Measurements. Special considerations regarding-dose and dose-volume prescribing and reporting in IMRT[J]. J ICRU,2010,10(1):27-40. DOI: 10.1093/jicru/ndq008.
[13] Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy[J]. Phys Med, 2007,23(3-4):115-125. DOI: 10.1016/j.ejmp.2007.07.001.
[14] Luxton G, Keall PJ, King CR. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD)[J]. Phys Med Biol, 2008,53(1):23-36. DOI: 10.1088/0031-9155/53/1/002.
[15] 朱健, 李宝生, 舒华忠, 等. 正常组织并发症概率模型综述[J].中国生物医学工程学报,2014,33(2):233-240. DOI: 10.3969/j.issn.0258-8021.2014.02.014.
Zhu J, Li BS, Shu HZ, et al. Review of normal tissues complication probability models[J].Chin J Biomed Eng,2014,33(2):233-240. DOI: 10.3969/j.issn.0258-8021.2014.02.014.
[16] Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function[J]. Int J Radiat Oncol Biol Phys, 1991,21(1):123-135. DOI: 10.1016/0360-3016(91)90172-z.
[17] Chen H, Huang Y, Wang H, et al.Dosimetric comparison and biological evaluation of fixed-jaw intensity-modulated radiation therapy for T-shaped esophageal cancer[J]. Radiat Oncol, 2021,16(1):158. DOI: 10.1186/s13014-021-01882-7.
[18] Wang L, Li CQ, Meng X, et al.Dosimetric and radiobiological comparison of external beam radiotherapy using simultaneous integrated boost technique for esophageal cancer in different location[J]. Front Oncol, 2019,9:674. DOI: 10.3389/fonc.2019.00674.
[19] Berry SL, Ma R, Boczkowski A, et al. Evaluating inter-campus plan consistency using a knowledge based planning model[J]. Radiother Oncol, 2016,120(2):349-355. DOI: 10.1016/j.radonc.2016.06.010.
[20] Hazell I, Bzdusek K, Kumar P, et al. Automatic planning of head and neck treatment plans[J]. J Appl Clin Med Phys, 2016,17(1):272-282. DOI: 10.1120/jacmp.v17i1.5901.
[21] Voet PW, Dirkx ML, Breedveld S, et al. Fully automated volumetric modulated arc therapy plan generation for prostate cancer patients[J]. Int J Radiat Oncol Biol Phys, 2014,88(5):1175-1179. DOI: 10.1016/j.ijrobp.2013. 12.046.
[22] Dumane VA, Tam J, Lo YC, et al. RapidPlan for knowledge-based planning of malignant pleural mesothelioma[J]. Pract Radiat Oncol, 2021,11(2):e219-e228. DOI: 10.1016/j.prro.2020.06.003.
[23] Marrazzo L, Meattini I, Arilli C, et al. Auto-planning for VMAT accelerated partial breast irradiation[J]. Radiother Oncol, 2019,132:85-92. DOI: 10.1016/j.radonc.2018. 11.006.
[24] Yang Y, Shao K, Zhang J, et al.Automatic planning for nasopharyngeal carcinoma based on progressive optimization in RayStation treatment planning system[J]. Technol Cancer Res Treat, 2020,19:1533033820915710. DOI: 10.1177/1533033820915710.
[25] 韩飞, 夏文龙, 马攀, 等. 基于预测可行性DVH的肝癌VMAT自动计划方法研究[J].中华放射肿瘤学杂志,2021,30(8):797-802. DOI: 10.3760/cma.j.cn113030-20210501-00183.
Han F, Xia WL, Ma P, et al. An automatic VMAT planning method for primary liver cancer radiotherapy based on predicting the feasibility DVH[J].Chin J Radiat Oncol,2021,30(8):797-802. DOI: 10.3760/cma.j.cn113030-20210501-00183.